Compare Honeywell International Inc (HON) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honeywell International Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Honeywell International Inc trades at $230.05 (market cap $71.66B), while Regeneron Pharmaceuticals Inc trades at $680.5 (market cap $70.47B). The key difference: Honeywell International Inc and Regeneron Pharmaceuticals Inc are close in size by market cap, and Honeywell International Inc pays the higher dividend (4.21%). Which is the better fit depends on your goals.
| HON | REGN | |
|---|---|---|
Market Cap | $71.66B | $70.47B |
Sector | Industrials | Health |
52-Week High | $248.04 | $812.27 |
52-Week Low | $188.14 | $545.46 |
Enterprise Value | $96.01B | $64.42B |
Dividend Yield | 4.21% | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
